N-ACETYL-CYSTEINE IN OCULAR THERAPY: A REVIEW OF THE LITERATURE
APPLICATIONS AND EFFICACY OF TOPICAL N-ACETYL-CYSTEINE IN A TERTIARY EYE REFERRAL CENTRE
Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)
EFFICACY OF INTRAVITREAL AFLIBERCEPT ADMINISTERED USING TREAT- AND-EXTEND REGIMEN OVER 2 YEARS IN PATIENTS WITH NEOVASCULAR AGE- RELATED MACULAR DEGENERATION: BASELINE CHARACTERISTICS OF ARIES
Investigation of Toxic Anterior Segment Syndrome (TASS) in a day surgery centre
RANDOMISED, OPEN-LABEL STUDY TO EVALUATE 2 INTRAVITREAL AFLIBERCEPT TREAT-AND-EXTEND DOSING REGIMENS IN WET AGE-RELATED MACULAR DEGENERATION: 52-WEEK OUTCOMES FROM ALTAIR
DIE ANOTHER DAY OR WALKING WITH DYING-SPHERES